Annual report pursuant to Section 13 and 15(d)

CAPITAL STOCK, STOCK PLANS, WARRANTS AND STOCK BASED COMPENSATION (Tables)

v3.23.1
CAPITAL STOCK, STOCK PLANS, WARRANTS AND STOCK BASED COMPENSATION (Tables)
12 Months Ended
Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]  
SCHEDULE OF STOCK OPTIONS VALUATION ASSUMPTIONS

 

                 
    Employee Stock
Options Granted
 
    2022     2021  
Weighted-average fair value per share   $ 2.71       3.51  
Risk -free interest rate (1)     3.00 %     1.05 %
Expected volatility of stock (2)     55.72 %     58.61 %
Dividend yield     None       None  
Expected option life (3)     5.0 years       5.0 years  

 

                 
    Outside Director Stock
Options Granted
 
    2022     2021  
Weighted-average fair value per share   $ 3.61     $ 3.9  
Risk -free interest rate (1)     2.91 %     1.23%-1.61%  
Expected volatility of stock (2)     55.04 %     55.84%-55.91%  
Dividend yield     None       None  
Expected option life (3)     10.0 years       10.0 years  

 

(1) The risk-free interest rate is based on the U.S. Treasury yield in effect at the grant date over the expected term of the option.

 

(2) The expected volatility is based on historical volatility from our traded Common Stock over the expected term of the option.

 

(3) The expected option life is based on historical exercises and post-vesting data.
SCHEDULE OF SHARE-BASED COMPENSATION, ALLOCATION OF RECOGNIZED PERIOD COSTS

The following table summarizes stock-based compensation recognized for fiscal years 2022 and 2021.

 

                 
    Year Ended  
    2022     2021  
Employee Stock Options   $ 313,000     $ 178,000  
Director Stock Options     95,000       72,000  
Total   $ 408,000     $ 250,000  
SCHEDULE OF STOCK OPTIONS ROLL FORWARD

The summary of the Company’s total plans as of December 31, 2022 and 2021, and changes during the period then ended are presented as follows:

 

    Shares     Weighted Average Exercise Price     Weighted Average Remaining Contractual Term (years)     Aggregate Intrinsic Value (2)  
Options outstanding January 1, 2022     1,019,400     $ 4.91               -  
Granted     94,000     $ 5.20                  
Exercised     (52,400 )   $ 4.04             $ 97,856  
Forfeited/expired     (42,600 )   $ 4.08                  
Options outstanding end of period (1)     1,018,400     $ 5.02       3.8     $ 44,262  
Options exercisable at December 31, 2022(1)     530,900     $ 4.27       2.4     $ 30,962  

 

    Shares     Weighted Average Exercise Price     Weighted Average Remaining Contractual Term (years)     Aggregate Intrinsic Value (2)  
Options outstanding January 1, 2021     658,400     $ 3.87               -  
Granted     381,000     $ 6.82                  
Exercised     (500 )   $ 3.15             $ 2,175  
Forfeited/expired     (19,500 )   $ 6.75                  
Options outstanding end of period (1)     1,019,400     $ 4.91       4.0     $ 1,669,687  
Options exercisable at December 31, 2021(1)     438,400     $ 3.95       2.7     $ 1,064,432  

 

(1) Options with exercise prices ranging from $2.79 to $7.50
(2) The intrinsic value of a stock option is the amount by which the market value of the underlying stock exceeds the exercise price
SCHEDULE OF NON VESTED OPTIONS

The summary of the Company’s nonvested options as of December 31, 2022 and changes during the period then ended are presented as follows:

 

          Weighted Average  
          Grant-Date  
    Shares     Fair Value  
Non-vested options January 1, 2022     581,000     $ 3.13  
Granted     94,000       3.39  
Vested     (154,500 )     2.67  
Forfeited     (33,000 )     3.08  
Non-vested options at December 31, 2022     487,500     $ 3.32